Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To compare ISB vs anterior and posterior approaches of suprascapular block in terms of lung function and analgesia
Interscalene block (ISB) is commonly used to provide pain control for shoulder surgeries. However, it is associated with several side effects, in particular, a high incidence of phrenic nerve blockade.
The suprascapular nerve block (SSB) has been proposed as an alternative to the ISB as it has a lower likelihood of causing phrenic nerve blockade. There are 2 commonly used approaches for the suprascapular nerve block, anterior and posterior. The anterior approach may still result in some degree of impairment of lung function.
The primary aim is to assess the pulmonary function after performance of ISB, aSSB and pSSB. Secondary outcomes are analgesic effects and incidence of adverse effects of these blocks.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ISB | Active Comparator | Interscalene brachial plexus block |
|
| aSSB | Active Comparator | Anterior Suprascapular Block |
|
| pSSB | Active Comparator | Posterior Suprascapular Block |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ISB | Procedure | ISB block with 0.5% ropivicaine 15mls ( 45mg ) |
| |
| aSSB |
| Measure | Description | Time Frame |
|---|---|---|
| Pulmonary function | To assess the pulmonary function after performance of interscalene, anterior and posterior approaches to the suprascapular block | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Analgesic effects and complications | Analgesic effect (pain scores, opioid consumption, opioid related side effects), degree of motor blockade and incidence of adverse effects of blocks (Horner's syndrome, hoarseness of voice) | 2 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yean Chin Lim | CGH | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Changi General Hospital | Singapore | 529889 | Singapore |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Procedure |
aSSB block with 0.5% ropivicaine 15mls ( 45mg ) |
|
| pSSB | Procedure | pSSB block with 0.5% ropivicaine 15mls ( 45mg ) |
|